OCGN (Ocugen Inc) Yalpi foyda bo'yicha rentabellik

Ocugen Corp (OCGN) kompaniyasining rasmiy ramzlari

Ocugen, Inc. (OCGN) minimal xarajatlar bilan ko'rlikni davolash uchun yuqori darajada kengayuvchan gen texnologiyalarini ishlab chiqmoqda. Kompaniya, yalpi foyda dinamikasi bilan tasdiqlanganidek, moslashuvchan madaniyat va aksiyalar opsion dasturlari orqali yetakchi olimlarni jalb qilmoqda. Ushbu ko'rsatkichning joriy darajasi 41.60 ni tashkil etadi, biroq daromadli tijorat mahsulotlarining yetishmasligi sababli biznes tashqi moliyalashtirishga tayanadi.

OCGN Ocugen Inc: Yalpi rentabellik 04.07.2022 - 20.11.2026 oraligʻida

Ocugen (OCGN) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- biznesning bozor baholash ko'rsatkichlari:
Fundamental baholash:Ocugen, Inc.
ocugen.com brendining mahsuloti

Noyob ko'rish qobiliyatini tiklash usullarini ishlab chiquvchi biotexnologiya platformasi Ocugen, Inc. (OCGN) uchun yalpi foyda marjasi uning patentlangan terapevtik yechimlarining monetizatsiya samaradorligini aks ettiradi. Ushbu ko'rsatkich daromad va bevosita ishlab chiqarish xarajatlari orasidagi farqning umumiy savdoga nisbati sifatida hisoblanadi, bu esa investorlarga Ocugen, Inc. (OCGN) kompaniyasining operatsion xarajatlar hisobga olinishidan oldin surunkali kasalliklarni davolashdan foyda olishning fundamental qobiliyatini baholash imkonini beradi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Pacific Biosciences of California, Inc. - Sotuvning yalpi rentabelligi|Benitec Biopharma - Yalpi foyda bo'yicha rentabellik|DSGN: Sotuvning yalpi rentabelligi|RCKT: Yalpi foyda bo'yicha rentabellik|FDMT - Yalpi marja|LXEO: Yalpi marja|Korro Bio Inc. - Yalpi foyda normasi|EDIT (editasmedicine.com) - Yalpi marja|Yalpi rentabellik SLN|Yalpi rentabellik ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning yalpi rentabelligi|Yalpi rentabellik Sangamo SGMO|NAUT: Sotuvning yalpi rentabelligi|MGX: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Precision BioSciences|GBIO (generationbio.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Yalpi marja|Sotuvning yalpi rentabelligi IMNN (Imunon, Inc.)|Yalpi marja PHIO|MBIO - Yalpi foyda marjasi|Yalpi marja RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik